CD44 and carcinoma: This change in morphology and protein expression pattern is associated with an acquisitionof breast cancer stem cell marker proteins ALDH-1 and CD44+/CD24−/low, which may play distinct functional roles in metaplastic carcinomas (Zhang et al., 2012).